- 现金
- 6559 元
- 精华
- 5
- 帖子
- 967
- 注册时间
- 2006-10-2
- 最后登录
- 2023-7-2
|
Symposium: Hepatitis B
A wave of new therapies on the horizon
This year marks the 50th anniversary of the discovery of the Australia antigen, which in 1967 was identified to be the hepatitis B virus surface antigen. Although much has been accomplished over the past five decades, current antiviral therapies for chronic hepatitis B only achieve the sustained clearance of infection in a minority of patients. Recent success in using combinations of drugs to cure almost all cases of chronic hepatitis C has stimulated interest in a similar approach to chronic hepatitis B. The articles in this symposium review the history, pathophysiology and current management of the disease, and describe a wave of newly identified drug targets, investigational compounds and experimental strategies that are now under clinical evaluation or in preclinical development.
Free access to the most recent papers
Chronic hepatitis B: A wave of new therapies on the horizon↗
Antiviral Research, Available online 22 June 2015
Timothy M. Block, Siddhartha Rawat, Carol L. Brosgart
Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure↗
Antiviral Research, Volume 121, September 2015, Pages 152–159
Jinhong Chang, Ju-Tao Guo
The hepatitis B virus ribonuclease H as a drug target↗
Antiviral Research, Volume 118, June 2015, Pages 132–138
John E. Tavis, Elena Lomonosova
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities↗
Antiviral Research, Available online 16 June 2015
Robert G. Gish, Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, David L. Lewis, Thomas Schlue
NTCP opens the door for hepatitis B virus infection↗
Antiviral Research, Available online 10 June 2015
Huan Yan, Yang Liu, Jianhua Sui, Wenhui Li
Modeling hepatitis B virus infection, immunopathology and therapy in mice↗
Antiviral Research, Volume 121, September 2015, Pages 1–8
Liang Cheng, Feng Li, Moses T. Bility, Christopher M. Murphy, Lishan Su
Core protein: A pleiotropic keystone in the HBV lifecycle↗
Antiviral Research, Volume 121, September 2015, Pages 82–93
Adam Zlotnick, Balasubramanian Venkatakrishnan, Zhenning Tan, Eric Lewellyn, William Turner, Samson Francis
Synthetic RNAi triggers and their use in chronic hepatitis B therapies 5 with curative intent↗
Antiviral Research, Volume 121, September 2015, Pages 97-108
Robert G. Gish, Man-Fung Yuen, Henry Lik Yuen Chan, Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, Christine I. Wooddell, Thomas Schluep, David L. Lewis
|
|